Program to date

Evening of August 16th, 2006

5:30 - 7:30 pm

Buffet Dinner
The residence of H.E. U.S. Ambassador Michael M. Wood
Welcoming remarks by Ms Barbro C. Ehnbom, Chairman SALSS

Program August 17th, 2006 at Kreab, Floragatan 13, Stockholm

8:30 am


9:00 am

Setting the stage: Moderator, Udayan Gupta,
WSJ Journalist and Author
View biografy about Udayan Gupta

9:10 am

Introductory remarks: To be announced

9:30 am

Keynote address: Dr. William Haseltine,
Chairman, Haseltine Global Health
Founder, Human Genome Science

10:00 am


10:10 am

Panel: Commercialization – From research to business
Moderator: Udayan Gupta
Introduction by Professor Mathias Uhlén

Perspective- Institute of higher learning
Harriet Wallberg-Henriksson, VD Karolinska Institutet

The Accelerated growth perspective
Dr. Yuval Binur, General Partner, Oxford BioScience

From Bench to Profit
Cynthia Ekberg Tsai, Managing Director,
Madelin Fund, MD Anderson

The Investors Perspective
Mikael Brönnegård, Director, HealthCare, InnKap

11.40 am


12:00 pm

The Swedish landscape – Company presentations
Medivir, Neuronova, Swedish Orphan

12:30 pm

Future outlook – what lies ahead

1:00 pm

Welcome: Charlotte Erkhammar, CEO, Kreab Group
Lunch speaker: Tony Svensson, Director ISA, New York

2.30 pm

Global Investment Trends 2006

3:00 pm

A Swedish success story
Laurent Leksell, Founder and Director, Elekta

3.30 pm


4:00 pm

Panel: Internationalization – Success Stories
Moderator: Udayan Gupta

Biacore GE Strategy
Peter von Ehrenheim, CEO, GE Healthcare Life Science

International Venture Capital Perspective
William Gedale, Managing Partner, NGN BioMed, L.P.

The I.P. Perspective
Dimitrios Drivas, White & Case

Analyst's Perspective, the LifeScience Market in Scandinavia
Benjamin Nordin, Head Analyst, Kaupthing bank

Reverse Merging
Dr. Robin L. Smith, Chairman, Neocell

Equity into Early Stage
Jay Lobell, President, Paramount BioCapital

5.30 pm

Concluding remarks by moderator

7.30 - 10:30 pm

Dinner Cruise around Stockholm

Program August 18th, 2006, Kreab, Floragatan 13 Stockholm

8.45 am

Coffee reception

9:00 am

Keynote speaker:
Professor Hans Wigzell, Scientific Advisor to the Swedish Government

9.30 am

The Swedish landscape – Company presentations
ActiveBiotech, LinkMed, Biolipox

10:00 am

Focus: This years topic - Life Science and the Developing World, from Bird Flu and the vaccines to the market potential in India and China
Moderator: Udayan Gupta

Swedish Venture Capital Perspective
Magnus Persson, HealthCap

Big corporate perspective
Niklas Prager, President of Pfizer in Sweden

Global overview
Head of Ernst & Young. Life Science Practice

From antiterrorism to cancer
Dr. Yakov Kogan, Chairman Cleveland BioLabs

Antiviral treatments of emerging pandemics
Dr. Johnson Lau, Managing Partner, Roth Capital

The Indian Connection
Parag Saxena, Vedanta Capital

11.30 am

Company presentations
In separate presentation rooms: Bionovo (U.S.), NeoCell (U.S)

12.00 pm

Final Remarks - Moderator

1:00 pm

Lunch at Grand Hotel
Hosted by Robert Charpentier, VD, Kaupthing Bank

For pre-registration,
please contact our New York Coordinator Ebba Kraemer
Phone: +46 (0)70 279 25 24

or our Stockholm Coordinator Mårten Hellberg
Phone: +46 (0)70 539 76 78

© Swedish American Life Science Summit 2006 |